The BASL main committee is made up of three principal officers - the President, the Secretary and the Treasurer. The chairs of the British Viral Hepatitis Group (BVHG), the BLNA (British Liver Nurses' Association) and the British Liver Transplant Group (BLTG) also sit on the main committee, as do the leads of the sub-committees covering services, research and education and training.
The work of the Committee:
The Committee works together to promote BASL’s aims within hepatology and to represent the interest of its members. Committee Members are also involved in many areas of work on behalf of BASL including contributing to NICE consultations.
The current BASL Committee Members are as follows:
|President (2021-2023)*||Dr Rebecca Jones, The Leeds Liver Unit based at St James’s University Hospital, Leeds|
|Past President (2019-2021)||Professor Guru Aithal, Nottingham Digestive Diseases Centre, University of Nottingham|
|Secretary*||Dr Michael Heneghan, King’s College Hospital, London|
|Secretary Elect||Prof Raj Mookerjee, University College London|
|Treasurer*||Dr James Ferguson, Queen Elizabeth Hospital, Birmingham|
|BLNA Chair*||Michelle Clayton, University of Leeds|
|BVHG Chair*||Dr Mark Aldersley, The Leeds Liver Unit based at St James's University Hospital, Leeds|
|BLTG Chair*||Dr Varuna Aluvihare, Kings College Hospital, London|
|Services Sub-Committee Chair*||Dr Simon Rushbrook, Norfolk and Norwich University Hospitals|
|Research Sub-Committee Chair*||Dr Ian Rowe, University of Leeds & Leeds Liver Unit, Leeds Teaching Hospitals NHS Trust|
|Education & Training Councillors X 2*||Dr Victoria Snowdon, Addenbrooke’s Hospital, Cambridge / Dr Kenneth Simpson, Edinburgh Royal Infirmary|
|Surgery Representative||Professor Brian Davidson, UCL and Royal Free Hopsital, London|
|Pathology Representative||Dr Tim Kendall, University of Edinburgh and Royal Infirmary of Edinburgh|
|Trainee Representatives||Dr Nadir Abbas, University of Birmingham|
|Paediatric Representative||Dr Jane Hartley, University Hospitals Birmingham|
|Communications Representative*||Dr Kate Drysdale, Hepatology Clinical Research Fellow, Barts Health & Queen Mary University of London|
|Scientist Representative*||Professor Fiona Oakley, Newcastle University|
|Patient Group Representative||Vanessa Hebditch, British Liver Trust|
|Public Affairs & External Relations||President|
*Governing Board Members
The Governing Board members are registered with Companies House in the UK as a Trustee (Director) of BASL.
Dr Rebecca Jones, The Leeds Liver Unit based at St James’s University Hospital, Leeds
Dr Jones studied Medicine at Oxford University and University College London and qualified in 1991. She undertook her specialist training in the South West of England and has worked in Liver Transplant Units in London (Royal Free), Birmingham and Melbourne, Australia. She was appointed as a consultant at the Bristol Royal Infirmary in 2003 before moving to the Leeds Liver Unit based at St James’s University Hospital, Leeds, UK in 2005. Dr Jones’s clinical interests include all aspects of hepatology and especially liver transplantation, hepatocellular carcinoma and immune related liver disease. She collaborates in research projects and clinical trials. She also has an interest in training, patient experience and the interface between primary, secondary and tertiary services. She co-founded the Yorkshire and Humber Liver Network in 2007. She was Lead Clinician for the Department of Hepatology at St James's between 2011-2019, and has held a number of other leadership roles in Leeds and nationally. These include serving on the Liver Advisory Group committee for NHSBT, the Hepatobiliary Specialist Services Clinical Reference Group for NHS-E and the Liver Section Committee of the British Society of Gastroenterology.
Professor Guruprasad P. Aithal, Nottingham Digestive Diseases Centre, University of Nottingham
Professor Aithal is Professor of Hepatology and Head of the Nottingham Digestive Diseases Centre, University of Nottingham. He leads the Gastrointestinal and Liver Disorder Theme of National Institute for Health Research Nottingham Biomedical Research Centre. He is the Deputy Director of the Medical Research Council (MRC) Nottingham Molecular Pathology Node. He has over 160 publications with H index of 45 currently. His research interests include Drug-induced Liver injury (DILI), non-alcoholic fatty liver disease (NAFLD), epidemiology of liver and biliary diseases, and hepatobiliary imaging, in particular the development of fast, and inexpensive magnetic resonance imaging (MRI) method as a toll to stratify patients with chronic liver diseases.
Professor Michael Heneghan, Clinical Director for Liver Services, Consultant Hepatologist & Reader in Hepatology, Institute of Liver Studies, King's College Hospital
Professor Heneghan graduated from University College Dublin in 1992 and trained in Gastroenterology and Hepatology at University College Hospital Galway, Kings College Hospital London, and Duke University Medical Centre. He also was an AASLD sponsored Advanced Fellow in Hepatology in 2000. He was appointed as an Assistant Prof in Gastroenterology at Duke University in 2001 and served as Medical Director of Liver Transplantation until 2003. He returned to Kings College Hospital London as a Consultant Hepatologist with an interest in autoimmune liver disease and liver transplantation in 2003. His research interests have focused around Autoimmune Liver Disease, Liver Transplantation, Pregnancy Related Liver Disease and aspects of Chronic Liver Disease. He has published over 100 papers in peer-reviewed journals and over 25 book chapters. He has a strong commitment to education having acted as a supervisor for postgraduate trainees, MD students and Ph.D. students. He has also been an active participant in local and national recruitment of trainees.
Professor Raj Mookerjee, Professor of Translational Hepatology at University College London, and Honorary Skou Professor in Hepatology in Aarhus University, Denmark.
Prof Mookerjee's research interests centre around experimental portal hypertension, biomarkers and novel targets for decompensated cirrhosis, and remote management of cirrhosis complications. He qualified with a First Class BSc and then a Distinction MBBS from Royal Free Medical School, London University. After graduating, he went onto pursue specialist training in gastroenterology and hepatology within the Central and North London Deanery, including Liver transplantation experience at The Royal Free. He completed his specialist training in 2005. During this period, he also completed a PhD in the Institute of Hepatology (UCL) that focussed on new mechanisms for portal hypertension and established an inflammatory basis for acute decompensation of cirrhosis. He then took up a post as Senior Lecturer and Consultant Hepatologist at UCLH and went onto to lead that service, before its migration and integration into the Royal Free Liver and Transplantation Unit in 2010, where he continues to be based.
He is on the steering committee of the European Foundation for the Study of Chronic Liver Failure of (EF-CLIF) and also serves on the educational committee for the European Association for the Study of the Liver, the National specialist training committee for Hepatology, and the BASL portal hypertension special interest group.
Dr James Ferguson, Queen Elizabeth Hospital, Birmingham
Dr Ferguson is a transplant hepatologist based at the Queen Elizabeth Hospital in Birmingham. He is the clinical lead on the IQILS (Improving quality in liver services) project and was a co-author of the recent lancet commission on liver disease in the UK.
Michelle Clayton RGN, BSc (Hons), MSc, PGC Clinical Education, University of Leeds
Michelle is a part time Lecturer in Liver Care at the University of Leeds and a part time Liver Nurse Educator at St. James’s University Hospital, Leeds. Michelle has over 25 years of experience in the field of hepatology and liver transplantation.
Michelle is passionate about championing quality care for people with liver disease. She has been integral in launching the British Liver Nurses’ Association (BLNA); she also holds a steering committee position on the RCN’s Gastrointestinal Forum. Michelle has a large portfolio of publications and speaks both nationally and internationally on care considerations for people with liver disease and liver transplantation. Michelle led and successfully launched the “Caring for People with Liver Disease: A Competence Framework for Nursing” in February 2013 and collaborated with Lynda Greenslade to update the framework in September 2015. She has recently been asked to join the EASL concerted action group for nurses to raise the profile of liver nursing across Europe.
In 2012, Michelle won Gastrointestinal Nursing’s “Educationist of the Year” award for her work in advancing liver nurse education and care. She is on the editorial board of Gastrointestinal Nursing and was integral in developing the journal’s Liver Nursing Supplement.
Dr Mark Aldersley, Leeds Liver Unit based at St James’s University Hospital, Leeds
Dr Aldersley graduated from the University of Southampton in 1987 before continuing his training in Coventry and Reading. In 1992 he was appointed as the first Leeds Liver Unit Hepatology Registrar and continued to work in West Yorkshire before completing his PhD thesis in molecular biology at the University of Leeds in 1998. He was appointed to his first Consultant Hepatologist post in Coventry in 1999 and also worked one day each week on the Birmingham Liver Unit until he returned to Leeds in 2005. His clinical interests are liver transplantation, viral hepatitis and alcohol and he is lead clinician for viral hepatitis in West Yorkshire and for clinical research in Hepatology.
Dr Varuna Aluvihare, King’s College Hospital, London
Dr Aluvihare is Transplant Hepatology and Governance Lead at the Institute of Liver Studies, King’s College Hospital, and Chair of the British Liver Transplant Group. He qualified at the Royal Free Hospital and completed his professional training at Addenbrooke’s Hospital, Cambridge. He undertook MRC funded Training (PhD) and Clinician Scientist fellowships in Immunology/Molecular Biology at the world renowned MRC Laboratory of Molecular Biology, University of Cambridge. He was awarded a 5-year HEFCE Senior Lecturer Fellowship and an ROTRF grant in transplantation research at King’s College Hospital. He is a member of the UK Liver Transplant Advisory Group, Hepatology representative on the National Multivisceral Transplantation Review Group, Transplant Hepatology representative on the British Transplant Society Council and a member of the Editorial Board for Liver Transplantation.
Dr Simon Rushbrook, Consultant Hepatologist, Norfolk and Norwich University Hospitals
Dr Rushbrook qualified in 1997 from the United and Medical Dental Schools of Guys and St Thomas’s. Having completed his House jobs in London he moved to Cambridge where he completed a 4 year PhD establishing the role of T regulatory cells in chronic viral hepatitis. During this time he gained experience in Liver transplantation and acute and chronic liver disease. He then undertook a further 3 years of training on the Cambridge Liver unit during his registrar training. During his PhD and training he undertook ERCP and EUS training and developed an interest in hepatobiliary disease, particularly PSC. During this time he has established a consortium of UK investigators to determine the genetic basis of PSC. His goals are to alongside his colleague Martin Phillips to develop a 2nd level hepatology unit for the East Anglian region.
Dr Ian Rowe, Associate Professor & Consultant Hepatologist, University of Leeds & Leeds Liver Unit, Leeds Teaching Hospitals NHS Trust
Dr Rowe trained at the University of Glasgow and, following general medical training at Queens Medical Centre in Nottingham, specialised in Gastroenterology and Hepatology in Birmingham. He was awarded a Medical Research Council Research Training Fellowship in 2009 and subsequently an NIHR Clinical Lectureship at the University of Birmingham and the Liver and Hepatobiliary Unit at the Queen Elizabeth Hospital Birmingham. In 2015 he was appointed as a University Academic Fellow at the University of Leeds and Honorary Consultant at the Leeds Liver Unit. His main research interests are in improving the outcomes of patients with liver disease and those following liver transplantation. His clinical practice is in hepatocellular carcinoma and liver transplantation.
Dr Victoria Snowdon, Consultant Hepatologist, Addenbrooke’s Hospital, Cambridge
Dr Snowdon was appointed as a Consultant Hepatologist at Addenbrookes in 2018. She qualified from Nottingham University in 2003. Her first exposure to Hepatology was working with Matthew Cramp in the Southwest in her medical house job, which enthused her to pursue a career in Hepatology. In 2010 she was awarded a Wellcome Trust Scottish Translational Medicine and Therapeutics Initiative (STMTI) to complete a PhD investigating renal dysfunction in cirrhosis and the role of Relaxin as a therapeutic modulator in liver disease at the University of Edinburgh, with Prof John Iredale, Prof Jonathan Fallowfield and Prof Peter Hayes. During these three years she worked in the Scottish Liver Transplant unit as a clinical fellow. She undertook her advanced liver year in Addenbrooke’s in 2014-15. She pursued further research and clinical training at Royal Free before finishing her training at Addenbrooke’s Hospital. Her academic and clinical focus is Hepatocellular carcinoma, Portal hypertension, Renal dysfunction in cirrhosis and education.
Dr Kenneth Simpson, Edinburgh Royal Infirmary
Dr Kenneth Simpson. Currently Senior Lecturer University of Edinburgh and Hon Consultant Physician Scottish Liver Transplantation Unit, Royal Infirmary, Edinburgh. Qualified University of Dundee 1983, research fellow MRC Clinical Research Centre, Northwick Park 1986-89, he trained in hepatology Kings College London, Royal Infirmary, Edinburgh and University of Michigan. His research interests are in liver transplantation, HEV infection, liver injury and failure.
Professor Brian Davidson, Royal Free Hospital, London
Professor Davidson is a consultant surgeon with a major interest in HPB surgery and liver transplant. He is UK editor of the Cochrane HPB group for evidence based healthcare and director of the UCL MSc in evidence based medicine. He works closely with patient groups on research advances in the HPB field and leads a research programme involving evidence based healthcare, organ preservation and tissue engineering, image guided surgery and novel approaches to the treatment of HPB cancers.
Dr Tim Kendall, Senior Clinical Fellow in Pathology, University of Edinburgh and Honorary Consultant Liver Pathologist, Royal Infirmary of Edinburgh
Dr Kendall's research interests are liver fibrogenesis and primary liver cancer but he provides histopathological support for many other preclinical, translational and clinical studies. He is a member of the UK Liver Pathology group research subcommittee, and he promotes histopathological involvement in trials through membership of the CM-Path Clinical Trials workstream, the NCRI Hepatobiliary CSG subgroup, and his role within the Lothian NRS Human Annotated Bioresource. Dr Kendall graduated from Southampton University Medical School, and trained in pathology in Southampton and Edinburgh.
Dr Nadir Abbas, University of Birmingham
Dr Abbas is a clinical research fellow at University of Birmingham working towards a PhD with research interests in immune mediated liver diseases and assessing surgical outcomes in liver cirrhosis patients. He has worked closely with national and international collaborators to evaluate real-world data with regards Primary biliary cholangitis (PBC).
He works as a clinician at the Birmingham Liver unit with clinical interests in Primary sclerosing cholangitis (PSC), Primary biliary cholangitis (PBC) and Liver transplantation. He believes in the power of collaboration to produce high-quality research and promoting hepatology as a speciality in junior doctors.
He has worked as an Associate College Tutor for HEWM and runs the Core procedural skills course at University of Birmingham and was awarded scholarship by HEE to complete postgraduate certification in Medical Education. He has media interest and has featured on various live TV shows and an Amazon documentary related to COVID-19 pandemic.
Dr Jane Hartley, University Hospitals Birmingham
Dr Jane Hartley is a Consultant Paediatric Hepatologist at Birmingham Children’s Hospital and clinical lead for the liver unit. She studied medicine at Leeds University before moving to Birmingham to train in paediatrics and then hepatology. Jane was awarded an MRC research training fellowship to complete a PhD in the genetics of liver disease where she identified the first gene for Phenotypic diarrhoea of infancy, studied primary cilia in the pathogenesis of biliary atresia and the intraflagellar transport system in ciliopathies resulting in publications in Nature Genetics, Nature immunology and Gastroenterology. Her current practice includes general paediatric hepatology and intestinal transplantation. She is an active member of the research committee for Children’s Liver Disease foundation.
Dr Kate Drysdale, Hepatology Clinical Research Fellow, Barts Health and Queen Mary University of London
Dr Drysdale is a clinical research fellow at Barts Health and is studying for her PhD at Queen Mary University of London. Her research interests include the impact of healthy policy and strategy on outcomes. Her PhD focuses on the treatment of chronic hepatitis C in England, using real-world data to evaluate services that contribute to disease elimination.
She graduated from University of Wales College of Medicine in 2005 and previously gained a BSc in Public Health from Cardiff University. She has worked clinically in Wales, New Zealand and London. From 2009 to 2011 she was a Clinical Advisor to the NHS Medical Director at the Department of Health. She plans to return to her South London training rotation after completion of her PhD.
Kate aims to improve BASL’s communications with and between members, people affected by liver disease and the wider hepatology community by harnessing the power of social media. She will also be championing diversity and sustainability in all of the association’s activities.
Professor Fiona Oakley, Newcastle University
Professor Oakley has an academic background in Physiology and Biochemistry having trained at Southampton University in Biological Sciences (BSc and Ph.D.). In 2000 she joined the Liver Group at Southampton University as a postdoctoral Research Scientist to study the role of NF-kappaB signalling in hepatic myofibroblast biology and liver fibrosis. In 2006 she was appointed to Lecturer at Newcastle University and was promoted to Professor of Fibrosis Biology in 2016. Her primary research interests focus on understanding the cellular and molecular mechanisms regulating liver fibrosis, regeneration and cancer.